OPTION TERMINATION AGREEMENTOption Termination Agreement • February 3rd, 2020 • Aevi Genomic Medicine, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 3rd, 2020 Company Industry JurisdictionTHIS OPTION TERMINATION AGREEMENT (this “Agreement”) is made as of January 30, 2020, by and between the undersigned (the “Option Holder”) and Aevi Genomic Medicine, Inc., a Delaware corporation (the “Company”).
LIMITED LIABILITY COMPANY AGREEMENT OF SECOND GENIE MERGER SUB, LLCLimited Liability Company Agreement • February 3rd, 2020 • Aevi Genomic Medicine, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 3rd, 2020 Company Industry JurisdictionTHIS LIMITED LIABILITY COMPANY AGREEMENT OF SECOND GENIE MERGER SUB, LLC, a Delaware limited liability company (the “Company”), is hereby adopted and approved by its sole member, Cerecor Inc., a Delaware corporation (the “Member”), and confirmed and agreed to by the Company effective as of November 27, 2019.